Author: bpc

Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs Agreements with Nine Companies Will Lower Prices of HIV Diagnosis and Two HIV/AIDS Medicines by 30-50 Percent for 50 Countries Clinton Also Confirms that Nearly a Quarter-Million People Living with HIV are Benefiting from First-Line HIV/AIDS Drug Agreements his… Continue reading Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs

JSE listed Aspen Pharmacare Holdings Limited and Lupin Limited of India have entered into an agreement to collaborate in the tuberculosis (TB) related products market in South Africa. The agreement involves cooperation in the areas of technology, manufacture and marketing. Stephen Saad, Aspen Group Chief Executive said, “the agreement enhances South Africa and Aspen’s ability… Continue reading Aspen and Lupin sign TB deal

Aspen Pharmacare Holdings Limited (Aspen) has signed definitive joint venture (JV) agreements with Indian-based Matrix Laboratories Limited (Matrix). The deals strengthen Aspen’s vertical integration into the manufacture of Active Pharmaceutical Ingredients (APIs), the key raw materials required in the manufacture of finished dosage form pharmaceuticals including anti-retrovirals (ARVs), and they unlock additional global supply and… Continue reading Aspen and India’s Matrix sign JVs

East London – Bevan Gogwana, MEC for health in the Eastern Cape officially opened Aspen Pharmacare’s Oral Contraceptive manufacturing facility earlier today. Stephen Saad, Group Chief Executive of Aspen Pharmacare, Southern Africa’s largest JSE-listed pharmaceutical company, said “the world-class oral contraceptive facility has been designed, built and validated to European standards, and has the capacity… Continue reading World-Class Oral Contraceptive Facility opened